Physiology and pathophysiology of the intrarenal renin-angiotensin system: An update

Journal of the American Society of Nephrology

Volumn 28, Issue 4, 2017, Pages 1040-1049

  Yang, Tianxin ^a,b   Xu, Chuanming ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CELL NUCLEUS RECEPTOR; KLOTHO PROTEIN; LIVER X RECEPTOR; PRORENIN RECEPTOR; PROSTAGLANDIN E2; VITAMIN D RECEPTOR; WNT PROTEIN;

HUMAN; HYPERTENSION; KIDNEY DISEASE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; WNT SIGNALING; ANIMAL; KIDNEY; PHYSIOLOGY;

ANIMALS; HUMANS; HYPERTENSION; KIDNEY; KIDNEY DISEASES; RENIN-ANGIOTENSIN SYSTEM;

EID: 85019186326     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/asn.2016070734     Document Type: Review

References (137)

1. Tigerstedt R, Bergman PG: Niere und kreislauf. Skand Arch Physiol 8: 223-271, 1898
2. Navar LG, Kobori H, Prieto MC, Gonzalez-Villalobos RA: Intratubular renin-angiotensin system in hypertension. Hypertension 57: 355-362, 2011
3. Suzaki Y, Prieto-Carrasquero MC, Kobori H: Intratubular renin-angiotensin system in hypertension. Curr Hypertens Rev 2: 151-157, 2006
4. Dzau VJ: Evolving concepts of the reninangiotensin system. Focus on renal and vascular mechanisms. Am J Hypertens 1: 334S-337S, 1988
5. Matsusaka T, Niimura F, Pastan I, Shintani A, Nishiyama A, Ichikawa I: Podocyte injury enhances filtration of liver-derived angiotensinogen and renal angiotensin II generation. Kidney Int 85: 1068-1077, 2014
6. JonesMR, Sealey JE, Laragh JH: Effects of angiotensin receptor blockers on ambulatory plasma renin activity in healthy, normal subjects during unrestricted sodium intake. Am J Hypertens 20: 907-916, 2007
7. Zhuo JL, Ferrao FM, Zheng Y, Li XC: New frontiers in the intrarenal renin-angiotensin system: A critical review of classical and new paradigms. Front Endocrinol (Lausanne) 4: 166, 2013
8. Kobori H, NangakuM, Navar LG, Nishiyama A: The intrarenal renin-angiotensin system: From physiology to the pathobiology of hypertension and kidney disease. Pharmacol Rev 59: 251-287, 2007
9. Navar LG, Prieto MC, Satou R, Kobori H: Intrarenal angiotensin II and its contribution to the genesis of chronic hypertension. Curr Opin Pharmacol 11: 180-186, 2011
10. Navar LG, Imig JD, Zou L, Wang CT: Intrarenal production of angiotensin II. Semin Nephrol 17: 412-422, 1997
11. Navar LG, Nishiyama A: Why are angiotensin concentrations so high in the kidney? CurrOpin Nephrol Hypertens 13: 107-115, 2004
12. Niimura F, Okubo S, Fogo A, Ichikawa I: Temporal and spatial expression pattern of the angiotensinogen gene in mice and rats. Am J Physiol 272: R142-R147, 1997
13. Ingelfinger JR, ZuoWM, Fon EA, Ellison KE, Dzau VJ: In situ hybridization evidence for angiotensinogen messenger RNA in the rat proximal tubule. An hypothesis for the intrarenal renin angiotensin system. J Clin Invest 85: 417-423, 1990
14. Kobori H, Harrison-Bernard LM, Navar LG: Expression of angiotensinogen mRNA and protein in angiotensin II-dependent hypertension. J Am Soc Nephrol 12: 431-439, 2001
15. Lara LS, McCormack M, Semprum-Prieto LC, Shenouda S, Majid DS, Kobori H, Navar LG, Prieto MC: AT1 receptor-mediated augmentation of angiotensinogen, oxidative stress, and inflammation in ANG II-salt hypertension. Am J Physiol Renal Physiol 302: F85-F94, 2012
16. Zhuo JL, Kobori H, Li XC, Satou R, Katsurada A, Navar LG: Augmentation of angiotensinogen expression in the proximal tubule by intracellular angiotensin II via AT1a/MAPK/NF-κB signaling pathways. Am J Physiol Renal Physiol 310: F1103-F1112, 2016
17. Rohrwasser A, Morgan T, Dillon HF, Zhao L, Callaway CW, Hillas E, Zhang S, Cheng T, Inagami T, Ward K, TerrerosDA, Lalouel JM: Elements of a paracrine tubular reninangiotensin system along the entire nephron. Hypertension 34: 1265-1274, 1999
18. Gonzalez AA, Liu L, Lara LS, SethDM, Navar LG, Prieto MC: Angiotensin II stimulates renin in innermedullary collecting duct cells via protein kinase C and independent of epithelial sodium channel and mineralocorticoid receptor activity. Hypertension 57: 594-599, 2011
19. Kang JJ, Toma I, Sipos A, Meer EJ, Vargas SL, Peti-Peterdi J: The collecting duct is the major source of prorenin in diabetes. Hypertension 51: 1597-1604, 2008
20. van Kats JP, Schalekamp MA, Verdouw PD, Duncker DJ, Danser AH: Intrarenal angiotensin II: Interstitial and cellular levels and site of production. Kidney Int 60: 2311-2317, 2001
21. Shao W, Seth DM, Navar LG: Augmentation of endogenous intrarenal angiotensin II levels in Val5-ANG II-infused rats. Am J Physiol Renal Physiol 296: F1067-F1071, 2009
22. Li XC, Hopfer U, Zhuo JL: AT1 receptormediated uptake of angiotensin II and NHE-3 expression in proximal tubule cells through a microtubule-dependent endocytic pathway. Am J Physiol Renal Physiol 297: F1342-F1352, 2009
23. Li XC, Carretero OA, Navar LG, Zhuo JL: AT1 receptor-mediated accumulation of extracellular angiotensin II in proximal tubule cells: Role of cytoskeleton microtubules and tyrosine phosphatases. Am J Physiol Renal Physiol 291: F375-F383, 2006
24. Li XC, Zhuo JL: In vivo regulation of AT1a receptor-mediated intracellular uptake of [125I]Val5-ANG II in the kidneys and adrenals of AT1a receptor-deficient mice. Am J Physiol Renal Physiol 294: F293-F302, 2008
25. Li XC, Navar LG, Shao Y, Zhuo JL: Genetic deletion of AT1a receptors attenuates intracellular accumulation of ANG II in the kidney of AT1a receptor-deficientmice. Am J Physiol Renal Physiol 293: F586-F593, 2007
26. Zhuo JL, Imig JD, Hammond TG, Orengo S, Benes E, Navar LG: Ang II accumulation in rat renal endosomes during Ang II-induced hypertension: Role of AT(1) receptor. Hypertension 39: 116-121, 2002
27. Zou LX, Imig JD, Hymel A, Navar LG: Renal uptake of circulating angiotensin II in Val5-angiotensin II infused rats is mediated by AT1 receptor. Am J Hypertens 11: 570-578, 1998
28. Pohl M, Kaminski H, Castrop H, Bader M, Himmerkus N, Bleich M, Bachmann S, Theilig F: Intrarenal renin angiotensin system revisited: Role of megalin-dependent endocytosis along the proximal nephron. J Biol Chem 285: 41935-41946, 2010
29. Roksnoer LC, Heijnen BF, Nakano D, Peti-Peterdi J, Walsh SB, Garrelds IM, van Gool JM, Zietse R, Struijker-Boudier HA, Hoorn EJ, Danser AH: On the origin of urinary renin: A translational approach. Hypertension 67: 927-933, 2016
30. Matsusaka T, Niimura F, Shimizu A, Pastan I, Saito A, Kobori H, Nishiyama A, Ichikawa I: Liver angiotensinogen is the primary source of renal angiotensin II. J Am Soc Nephrol 23: 1181-1189, 2012
31. Ramkumar N, Stuart D, Calquin M, Wang S, Niimura F, Matsusaka T, KohanDE: Possible role for nephron-derived angiotensinogen in angiotensin-II dependent hypertension. Physiol Rep 4: E12675, 2016
32. Gonzalez-Villalobos RA, Satou R, Ohashi N, Semprun-Prieto LC, Katsurada A, Kim C, Upchurch GM, Prieto MC, Kobori H, Navar LG: Intrarenal mouse renin-angiotensin system during ANG II-induced hypertension and ACE inhibition. Am J Physiol Renal Physiol 298: F150-F157, 2010
33. Gonzalez-Villalobos RA, Satou R, Seth DM, Semprun-Prieto LC, Katsurada A, Kobori H, Navar LG: Angiotensin-converting enzymederived angiotensin II formation during angiotensin II-induced hypertension. Hypertension 53: 351-355, 2009
34. Cole J, Quach DL, Sundaram K, Corvol P, Capecchi MR, Bernstein KE: Mice lacking endothelial angiotensin-converting enzyme have a normal blood pressure. Circ Res 90: 87-92, 2002
35. Gonzalez-Villalobos RA, Janjoulia T, Fletcher NK, Giani JF, NguyenMT, Riquier-Brison AD, Seth DM, Fuchs S, Eladari D, Picard N, Bachmann S, Delpire E, Peti-Peterdi J, Navar LG, Bernstein KE, McDonough AA: The absence of intrarenal ACE protects against hypertension. J Clin Invest 123: 2011-2023, 2013
36. Giani JF, Shah KH, Khan Z, Bernstein EA, Shen XZ, McDonough AA, Gonzalez-Villalobos RA, Bernstein KE: The intrarenal generation of angiotensin II is required for experimental hypertension. Curr Opin Pharmacol 21: 73-81, 2015
37. Crowley SD, Gurley SB, Oliverio MI, Pazmino AK, Griffiths R, Flannery PJ, Spurney RF, Kim HS, Smithies O, Le TH, Coffman TM: Distinct roles for the kidney and systemic tissues in blood pressure regulation by the renin-angiotensin system. J Clin Invest 115: 1092-1099, 2005
38. Gurley SB, Riquier-Brison AD, Schnermann J, Sparks MA, Allen AM, Haase VH, Snouwaert JN, Le TH, McDonough AA, Koller BH, Coffman TM: AT1A angiotensin receptors in the renal proximal tubule regulate blood pressure. Cell Metab 13: 469-475, 2011
39. Ramkumar N, Stuart D, Rees S, Hoek AV, Sigmund CD, Kohan DE: Collecting ductspecific knockout of renin attenuates angiotensin II-induced hypertension. Am J Physiol Renal Physiol 307: F931-F938, 2014
40. Ramkumar N, Ying J, Stuart D, Kohan DE: Overexpression of renin in the collecting duct causes elevated blood pressure. Am J Hypertens 26: 965-972, 2013
41. Ramkumar N, Kohan DE: Role of collecting duct renin in blood pressure regulation. Am J Physiol Regul Integr Comp Physiol 305: R92-R94, 2013
42. Kobori H, Nishiyama A, Abe Y, Navar LG: Enhancement of intrarenal angiotensinogen in Dahl salt-sensitive rats on high salt diet. Hypertension 41: 592-597, 2003
43. Kim YG, Lee SH, Kim SY, Lee A, Moon JY, Jeong KH, Lee TW, Lim SJ, Sohn IS, Ihm CG: Sequential activation of the intrarenal renin-angiotensin system in the progression of hypertensive nephropathy in Goldblatt rats. Am J Physiol Renal Physiol 311: F195-F206, 2016
44. Takenaka T, Suzuki H, Furukawa T, Ogata Y, Saruta T: Role of intrarenal renin-angiotensin system on pressure-natriuresis in spontaneously hypertensive rats. Clin ExpHypertens A 12: 1377-1394, 1990
45. Zhou L, Mo H, Miao J, Zhou D, Tan RJ, Hou FF, Liu Y: Klotho ameliorates kidney injury and fibrosis and normalizes blood pressure by targeting the renin-angiotensin system. Am J Pathol 185: 3211-3223, 2015
46. Saigusa T, Dang Y, Bunni MA, Amria MY, Steele SL, Fitzgibbon WR, Bell PD: Activation of the intrarenal renin-angiotensinsystem in murine polycystic kidney disease. Physiol Rep 3: 12405, 2015
47. Graciano ML, Cavaglieri RC, Dellê H, Dominguez WV, Casarini DE, Malheiros DM, Noronha IL: Intrarenal renin-angiotensin system is upregulated in experimental model of progressive renal disease induced by chronic inhibition of nitric oxide synthesis. J AmSocNephrol 15: 1805-1815, 2004
48. Rafiq K, Noma T, Fujisawa Y, Ishihara Y, Arai Y, Nabi AH, Suzuki F, Nagai Y, Nakano D, Hitomi H, Kitada K, UrushiharaM, Kobori H, Kohno M, Nishiyama A: Renal sympathetic denervation suppresses de novo podocyte injury and albuminuria in rats with aortic regurgitation. Circulation 125: 1402-1413, 2012
49. Yang X, Chen C, Tian J, Zha Y, Xiong Y, Sun Z, Chen P, Li J, Yang T, Ma C, Liu H, Wang X, Hou FF: Urinary angiotensinogen level predicts AKI in acute decompensated heart failure: A prospective, two-stage study. J Am Soc Nephrol 26: 2032-2041, 2015
50. Kobori H, Harrison-Bernard LM, Navar LG: Urinary excretion of angiotensinogen reflects intrarenal angiotensinogen production. Kidney Int 61: 579-585, 2002
51. Yamamoto T, Nakagawa T, Suzuki H, Ohashi N, Fukasawa H, Fujigaki Y, Kato A, Nakamura Y, Suzuki F, Hishida A: Urinary angiotensinogen as a marker of intrarenal angiotensin II activity associated with deterioration of renal function in patients with chronic kidney disease. J Am Soc Nephrol 18: 1558-1565, 2007
52. MacFadyen RJ, Lee AF, Morton JJ, Pringle SD, Struthers AD: How often are angiotensin II and aldosterone concentrations raised during chronic ACE inhibitor treatment in cardiac failure? Heart 82: 57-61, 1999
53. Nguyen G, Delarue F, Burcklé C, Bouzhir L, Giller T, Sraer JD: Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin. J Clin Invest 109: 1417-1427, 2002
54. Burcklé C, BaderM: Prorenin and its ancient receptor. Hypertension 48: 549-551, 2006
55. Cousin C, Bracquart D, Contrepas A, Corvol P, Muller L, Nguyen G: Soluble form of the (pro)renin receptor generated by intracellular cleavage by furin is secreted in plasma. Hypertension 53: 1077-1082, 2009
56. Cruciat CM, Ohkawara B, Acebron SP, Karaulanov E, Reinhard C, Ingelfinger D, Boutros M, Niehrs C: Requirement of prorenin receptor and vacuolar H+-ATPasemediated acidification for Wnt signaling. Science 327: 459-463, 2010
57. Lu X, Wang F, LiuM, Yang KT, Nau A, Kohan DE, Reese VR, Richardson RS, Yang T: Activation of ENaC in collecting duct cells by prorenin and its receptor PRR: Involvement of Nox4-derived hydrogen peroxide. Am J Physiol Renal Physiol 310: F1243-F1250, 2015
58. Yang T: Crosstalk between (pro)renin receptor and COX-2 in the renal medulla during angiotensin II-induced hypertension. Curr Opin Pharmacol 21: 89-94, 2015
59. Huang J, Siragy HM: Sodium depletion enhances renal expression of (pro)renin receptor via cyclic GMP-protein kinase G signaling pathway. Hypertension 59: 317-323, 2012
60. Matavelli LC, Huang J, Siragy HM: In vivo regulation of renal expression of (pro)renin receptor by a low-sodiumdiet. Am J Physiol Renal Physiol 303: F1652-F1657, 2012
61. Sihn G, Rousselle A, Vilianovitch L, Burckle C, Bader M: Physiology of the (pro)renin receptor: Wnt of change? Kidney Int 78: 246-256, 2010
62. Trepiccione F, Gerber SD, Grahammer F, López-Cayuqueo KI, Baudrie V, Pǎunescu TG, Capen DE, Picard N, Alexander RT, Huber TB, Chambrey R, Brown D, Houillier P, EladariD, SimonsM: Renal Atp6ap2/(pro) renin receptor is required for normal vacuolar H+-ATPase function but not for the renin-angiotensin system. J Am Soc Nephrol 27: 3320-3330, 2016
63. Krop M, Lu X, Danser AH, Meima ME: The (pro)renin receptor. A decade of research: What have we learned? Pflugers Arch 465: 87-97, 2013
64. Kaneshiro Y, Ichihara A, Sakoda M, Takemitsu T, Nabi AH, Uddin MN, Nakagawa T, Nishiyama A, Suzuki F, Inagami T, Itoh H: Slowly progressive, angiotensin II-independent glomerulosclerosis in human (pro)renin receptor-transgenic rats. J AmSocNephrol 18: 1789-1795, 2007
65. Nguyen G: Renin, (pro)renin and receptor: An update. Clin Sci (Lond) 120: 169-178, 2011
66. Rousselle A, Sihn G, Rotteveel M, Bader M: (Pro)renin receptor and V-ATPase: From Drosophila to humans. Clin Sci (Lond) 126: 529-536, 2014
67. Feldt S, Maschke U, Dechend R, Luft FC, Muller DN: The putative (pro)renin receptor blocker HRP fails to prevent (pro) renin signaling. J AmSocNephrol 19: 743-748, 2008
68. Advani A, Kelly DJ, Cox AJ, White KE, Advani SL, Thai K, Connelly KA, Yuen D, Trogadis J, Herzenberg AM, Kuliszewski MA, Leong-Poi H, Gilbert RE: The (pro)renin receptor: Site-specific and functional linkage to the vacuolar H+-ATPase in the kidney. Hypertension 54: 261-269, 2009
69. Gonzalez AA, Lara LS, Luffman C, Seth DM, Prieto MC: Soluble form of the (pro)renin receptor is augmented in the collecting duct and urine of chronic angiotensin IIdependent hypertensive rats. Hypertension 57: 859-864, 2011
70. Gonzalez AA, Womack JP, Liu L, Seth DM, Prieto MC: Angiotensin II increases the expression of (pro)renin receptor during lowsalt conditions. AmJMed Sci 348: 416-422, 2014
71. Li W, Sullivan MN, Zhang S, Worker CJ, Xiong Z, Speth RC, Feng Y: Intracerebroventricular infusion of the (pro)renin receptor antagonist PRO20 attenuates deoxycorticosterone acetate-salt-induced hypertension. Hypertension 65: 352-361, 2015
72. Wang F, Lu X, Liu M, Feng Y, Zhou SF, Yang T: Renal medullary (pro)renin receptor contributes to angiotensin II-induced hypertension in rats via activation of the local renin-angiotensin system. BMC Med 13: 278, 2015
73. Peng K, Lu X, Wang F, Nau A, Chen R, Zhou SF, Yang T: Collecting duct (pro)renin receptor targets ENaC to mediate angiotensin II-induced hypertension [published online ahead of print April 27, 2010]. Am J Physiol Renal Physiol doi:10.1152/ajprenal.00178. 2016
74. RamkumarN, Stuart D, Mironova E, Bugay V, Wang S, Abraham N, Ichihara A, Stockand JD, Kohan DE: Renal tubular epithelial cell prorenin receptor regulates blood pressure and sodium transport. Am J Physiol Renal Physiol 311: F186-F194, 2016
75. Lu X, Wang F, LiuM, Yang KT, Nau A, Kohan DE, Reese V, Richardson RS, Yang T: Activation of ENaC in collecting duct cells by prorenin and its receptor PRR: Involvement of Nox4-derived hydrogen peroxide. Am J Physiol Renal Physiol 310: F1243-F1250, 2016
76. Danser AH: The role of the (pro)renin receptor in hypertensive disease. Am J Hypertens 28: 1187-1196, 2015
77. Schnermann J, Briggs JP: Synthesis and secretion of renin in mice with induced genetic mutations. Kidney Int 81: 529-538, 2012
78. Schnermann J, Briggs JP: Tubular control of renin synthesis and secretion. Pflugers Arch 465: 39-51, 2013
79. Mann B, Hartner A, Jensen BL, Kammerl M, Krämer BK, Kurtz A: Furosemide stimulates macula densa cyclooxygenase-2 expression in rats. Kidney Int 59: 62-68, 2001
80. Greenberg SG, Lorenz JN, He XR, Schnermann JB, Briggs JP: Effect of prostaglandin synthesis inhibition on macula densa-stimulated renin secretion. Am J Physiol 265: F578-F583, 1993
81. Schweda F, Klar J, Narumiya S, Nüsing RM, Kurtz A: Stimulation of renin release by prostaglandin E2 is mediated by EP2 and EP4 receptors in mouse kidneys. Am J Physiol Renal Physiol 287: F427-F433, 2004
82. Pöschke A, Kern N, Maruyama T, Pavenstädt H, Narumiya S, Jensen BL, Nüsing RM: The PGE(2)-EP4 receptor is necessary for stimulation of the renin-angiotensin-aldosterone system in response to low dietary salt intake in vivo. Am J Physiol Renal Physiol 303: F1435-F1442, 2012
83. Farman N, Pradelles P, Bonvalet JP: Determination of prostaglandin E2 synthesis along rabbit nephron by enzyme immunoassay. Am J Physiol 251: F238-F244, 1986
84. Breyer MD, Jacobson HR, Breyer RM: Functional and molecular aspects of renal prostaglandin receptors. J Am Soc Nephrol 7: 8-17, 1996
85. Olesen ET, RützlerMR, Moeller HB, Praetorius HA, Fenton RA: Vasopressin-independent targeting of aquaporin-2 by selective Eprostanoid receptor agonists alleviates nephrogenic diabetes insipidus. Proc Natl Acad Sci USA 108: 12949-12954, 2011
86. Gao M, Cao R, Du S, Jia X, Zheng S, Huang S, Han Q, Liu J, Zhang X, Miao Y, Kang J, Gustafsson JA, Guan Y: Disruption of prostaglandin E2 receptor EP4 impairs urinary concentration via decreasing aquaporin 2 in renal collecting ducts. Proc Natl Acad Sci USA 112: 8397-8402, 2015
87. Wang F, Lu X, Peng K, FangH, Zhou L, Su J, Nau A, Yang KT, Ichihara A, Lu A, Zhou SF, Yang T: Antidiuretic action of collecting duct (pro)Renin receptor downstream of vasopressin and PGE2 receptor EP4. J Am Soc Nephrol 27: 3022-3034, 2016
88. Breyer MD, Breyer RM: Prostaglandin receptors: Their role in regulating renal function. CurrOpinNephrolHypertens 9: 23-29, 2000
89. Vo BT, Morton D Jr., Komaragiri S, Millena AC, Leath C, Khan SA: TGF-b effects on prostate cancer cell migration and invasion aremediated by PGE2 through activation of PI3K/AKT/mTOR pathway. Endocrinology 154: 1768-1779, 2013
90. Thibodeau JF, Holterman CE, He Y, Carter A, Cron GO, Boisvert NC, Abd-Elrahman KS, Hsu KJ, Ferguson SS, Kennedy CR: Vascular smooth muscle-specific EP4 receptor deletion in mice exacerbates angiotensin II-induced renal injury. Antioxid Redox Signal 25: 642-656, 2016
91. Angers S, Moon RT: Proximal events inWnt signal transduction. Nat Rev Mol Cell Biol 10: 468-477, 2009
92. Schmidt-Ott KM, Barasch J: WNT/betacatenin signaling in nephron progenitors and their epithelial progeny. Kidney Int 74: 1004-1008, 2008
93. He W, Kang YS, Dai C, Liu Y: Blockade of Wnt/b-catenin signaling by paricalcitol ameliorates proteinuria and kidney injury. J Am Soc Nephrol 22: 90-103, 2011
94. HeW, Dai C, Li Y, Zeng G, Monga SP, Liu Y: Wnt/beta-catenin signaling promotes renal interstitial fibrosis. J Am Soc Nephrol 20: 765-776, 2009
95. Zhou T, He X, Cheng R, Zhang B, Zhang RR, Chen Y, Takahashi Y, Murray AR, Lee K, Gao G, Ma JX: Implication of dysregulation of the canonical wingless-type MMTV integration site (WNT) pathway in diabetic nephropathy. Diabetologia 55: 255-266, 2012
96. Zhou L, Li Y, Hao S, Zhou D, Tan RJ, Nie J, Hou FF, KahnM, Liu Y:Multiple genes of the renin-angiotensin system are novel targets of Wnt/b-catenin signaling. J Am Soc Nephrol 26: 107-120, 2015
97. Cuevas CA, Gonzalez AA, Inestrosa NC, Vio CP, Prieto MC: Angiotensin II increases fibronectin and collagen I through the b-catenin-dependent signaling in mouse collecting duct cells. Am J Physiol Renal Physiol 308: F358-F365, 2015
98. Lu X, Wang F, XuC, Soodvilai S, PengK, Su J, Zhao L, Yang KT, Feng Y, Zhou S-F, Gustafsson J-A, Yang T: Soluble (pro)renin receptor via b-catenin enhances urine concentration capability: A target of liver X receptor. Proc Natl Acad Sci USA 113: E1898-E1906, 2016
99. Kuro-o M, Matsumura Y, Aizawa H, Kawaguchi H, Suga T, Utsugi T, Ohyama Y, Kurabayashi M, Kaname T, Kume E, Iwasaki H, Iida A, Shiraki-Iida T, Nishikawa S, Nagai R, Nabeshima YI: Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 390: 45-51, 1997
100. Hu MC, , Kuro-o M, , Moe OW, : Klotho and chronic kidney disease. Contrib Nephrol 180: 47-63, 2013.
101. Hamada K, Taniguchi Y, Shimamura Y, Inoue K, Ogata K, IshiharaM, Horino T, Fujimoto S, Ohguro T, Yoshimoto Y, Ikebe M, Yuasa K, Hoshino E, Iiyama T, Ichihara A, Terada Y: Serum level of soluble (pro)renin receptor is modulated in chronic kidney disease. Clin Exp Nephrol 17: 848-856, 2013
102. Yang HC, Deleuze S, Zuo Y, Potthoff SA, Ma LJ, Fogo AB: The PPARgamma agonist pioglitazone ameliorates aging-related progressive renal injury. J Am Soc Nephrol 20: 2380-2388, 2009
103. Mitani H, Ishizaka N, Aizawa T, Ohno M, Usui S, Suzuki T, Amaki T, Mori I, Nakamura Y, Sato M, Nangaku M, Hirata Y, Nagai R: In vivo klotho gene transfer ameliorates angiotensin II-induced renal damage. Hypertension 39: 838-843, 2002
104. Zhou L, Li Y, Zhou D, Tan RJ, Liu Y: Loss of Klotho contributes to kidney injury by derepression of Wnt/b-catenin signaling. J Am Soc Nephrol 24: 771-785, 2013
105. Zhou X, Chen K, Wang Y, SchumanM, Lei H, Sun Z: Antiaging gene Klotho regulates adrenal CYP11B2 expression and aldosterone synthesis. J AmSocNephrol 27: 1765-1776, 2016
106. Gustafsson JA: Historical overview of nuclear receptors. J Steroid BiochemMol Biol 157: 3-6, 2016
107. Zhang H, Zhang A, Kohan DE, Nelson RD, Gonzalez FJ, Yang T:Collecting duct-specific deletion of peroxisome proliferator-activated receptor gamma blocks thiazolidinedioneinduced fluid retention. Proc Natl Acad Sci USA 102: 9406-9411, 2005
108. Guan Y, Hao C, Cha DR, Rao R, LuW, Kohan DE, Magnuson MA, Redha R, Zhang Y, Breyer MD: Thiazolidinediones expand body fluid volume through PPARgamma stimulation of ENaC-mediated renal salt absorption. Nat Med 11: 861-866, 2005
109. Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP: 1, 25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 110: 229-238, 2002
110. Li YC: Discovery of vitamin D hormone as a negative regulator of the renin-angiotensin system. Clin Chem60: 561-562, 2014
111. Li YC: Vitamin D receptor signaling in renal and cardiovascular protection. Semin Nephrol 33: 433-447, 2013
112. Kristal-Boneh E, Froom P, Harari G, Ribak J: Association of calcitriol and blood pressure in normotensive men. Hypertension 30: 1289-1294, 1997
113. Lind L, Hänni A, Lithell H, Hvarfner A, Sörensen OH, Ljunghall S: Vitamin D is related to blood pressure and other cardiovascular risk factors in middle-aged men. Am J Hypertens 8: 894-901, 1995
114. Resnick LM, Müller FB, Laragh JH: Calciumregulating hormones in essential hypertension. Relation to plasma renin activity and sodium metabolism. Ann Intern Med 105: 649-654, 1986
115. YuanW, PanW, Kong J, ZhengW, Szeto FL, Wong KE, Cohen R, Klopot A, Zhang Z, Li YC: 1, 25-dihydroxyvitamin D3 suppresses renin gene transcription by blocking the activity of the cyclic AMP response element in the renin gene promoter. J Biol Chem 282: 29821-29830, 2007
116. Freundlich M, Quiroz Y, Zhang Z, Zhang Y, Bravo Y, Weisinger JR, Li YC, Rodriguez-Iturbe B: Suppression of renin-angiotensin gene expression in the kidney by paricalcitol. Kidney Int 74: 1394-1402, 2008
117. Scragg R, Sowers M, Bell C: Serum 25-hydroxyvitamin D, ethnicity, and blood pressure in the Third National Health and Nutrition Examination Survey. Am J Hypertens 20: 713-719, 2007
118. Pittas AG, Chung M, Trikalinos T, Mitri J, Brendel M, Patel K, Lichtenstein AH, Lau J, Balk EM: Systematic review: Vitamin D and cardiometabolic outcomes. Ann Intern Med 152: 307-314, 2010
119. WithamMD, NadirMA, Struthers AD: Effect of vitamin D on blood pressure: A systematic review and meta-analysis. J Hypertens 27: 1948-1954, 2009
120. Margolis KL, Ray RM, Van Horn L, Manson JE, Allison MA, Black HR, Beresford SA, Connelly SA, Curb JD, Grimm RH Jr., Kotchen TA, Kuller LH, Wassertheil-Smoller S, Thomson CA, Torner JC; Women's Health Initiative Investigators: Effect of calcium and vitamin D supplementation on blood pressure: The women's health initiative randomized trial. Hypertension 52: 847-855, 2008
121. Beveridge LA, Struthers AD, Khan F, Jorde R, Scragg R, Macdonald HM, Alvarez JA, Boxer RS, Dalbeni A, Gepner AD, Isbel NM, Larsen T, Nagpal J, PetcheyWG, Stricker H, Strobel F, Tangpricha V, Toxqui L, Vaquero MP, Wamberg L, Zittermann A, Witham MD; D-PRESSURE Collaboration: Effect of vitamin D supplementation on blood pressure: A systematic review andmeta-analysis incorporating individual patient data. JAMA Intern Med 175: 745-754, 2015
122. Pilz S, Gaksch M, Kienreich K, Grübler M, Verheyen N, Fahrleitner-Pammer A, Treiber G, Drechsler C, Ó Hartaigh B, Obermayer-Pietsch B, Schwetz V, Aberer F, Mader J, Scharnagl H, Meinitzer A, Lerchbaum E, Dekker JM, Zittermann A, März W, Tomaschitz A: Effects of vitamin D on blood pressure and cardiovascular risk factors: A randomized controlled trial. Hypertension 65: 1195-1201, 2015
123. Wu SH, Ho SC, Zhong L: Effects of vitaminD supplementation on blood pressure. South Med J 103: 729-737, 2010
124. Beveridge LA, Witham MD: Controversy in the link between vitamin D supplementation and hypertension. Expert Rev Cardiovasc Ther 13: 971-973, 2015
125. Artaza JN, Contreras S, Garcia LA, Mehrotra R, Gibbons G, Shohet R, Martins D, Norris KC: Vitamin D and cardiovascular disease: Potential role in health disparities. J Health Care Poor Underserved 22[Suppl]: 23-38, 2011
126. Berkenstam A, Gustafsson JA: Nuclear receptors and their relevance to diseases related to lipid metabolism. Curr Opin Pharmacol 5: 171-176, 2005
127. Alberti S, Steffensen KR, Gustafsson JA: Structural characterisation of the mouse nuclear oxysterol receptor genes LXRalpha and LXRbeta. Gene 243: 93-103, 2000
128. Zelcer N, Hong C, Boyadjian R, Tontonoz P: LXR regulates cholesterol uptake through Idol-dependent ubiquitination of the LDL receptor. Science 325: 100-104, 2009
129. Repa JJ, Turley SD, Lobaccaro JA, Medina J, Li L, Lustig K, Shan B, Heyman RA, Dietschy JM, Mangelsdorf DJ: Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers. Science 289: 1524-1529, 2000
130. Wang F, Lu X, Peng K, Du Y, Zhou SF, Zhang A, Yang T: Prostaglandin E-prostanoid4 receptor mediates angiotensin II-induced (pro) renin receptor expression in the rat renal medulla. Hypertension 64: 369-377, 2014
131. Kuipers I, van derHarst P, Kuipers F, vanGenne L, Goris M, Lehtonen JY, van Veldhuisen DJ, van Gilst WH, de Boer RA: Activation of liver X receptor-alpha reduces activation of the renal and cardiac renin-angiotensin-aldosterone system. Lab Invest 90: 630-636, 2010
132. Morello F, de Boer RA, Steffensen KR, Gnecchi M, Chisholm JW, Boomsma F, Anderson LM, Lawn RM, Gustafsson JA, Lopez-Ilasaca M, Pratt RE, Dzau VJ: Liver X receptors alpha and beta regulate renin expression in vivo. J Clin Invest 115: 1913-1922, 2005
133. Hao S, HeW, Li Y, Ding H, Hou Y, Nie J, Hou FF, Kahn M, Liu Y: Targeted inhibition of b-catenin/CBP signaling ameliorates renal interstitial fibrosis. J Am Soc Nephrol 22: 1642-1653, 2011
134. Yang M, Wang R, Sun J, Yu K, Chen B, Xu L, Zhao B, Wang H: The liver X receptor agonist TO901317 protects mice against cisplatininduced kidney injury. ExpBiolMed(Maywood) 240: 1717-1727, 2015
135. HumJM, O'Bryan LM, TatiparthiAK, CassTA, Clinkenbeard EL, Cramer MS, Bhaskaran M, Johnson RL, Wilson JM, Smith RC, White KE: Chronic hyperphosphatemia and vascular calcification are reduced by stable delivery of soluble Klotho [published online ahead of print November 11, 2016]. J AmSoc Nephrol doi 10.1681/ASN.2015111266
136. Shimamura Y, Hamada K, Inoue K, Ogata K, Ishihara M, Kagawa T, Inoue M, Fujimoto S, Ikebe M, Yuasa K, Yamanaka S, Sugiura T, Terada Y: Serum levels of soluble secreted a-Klotho are decreased in the early stages of chronic kidney disease, making it a probable novel biomarker for early diagnosis. Clin Exp Nephrol 16: 722-729, 2012
137. KitagawaM, Sugiyama H, Morinaga H, Inoue T, Takiue K, Ogawa A, Yamanari T, Kikumoto Y, Uchida HA, Kitamura S, Maeshima Y, Nakamura K, Ito H, Makino H: A decreased level of serum soluble Klotho is an independent biomarker associatedwith arterial stiffness in patients with chronic kidney disease. PLoS One 8: E56695, 2013